Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device for Intracranial Aneurysms

NCT05543447 is registered in ClinicalTrials.gov with Acandis GmbH as lead sponsor.

NCT NCT05543447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05543447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DERIVO® 2heal® Study: Clinical Safety and Efficacy of the DERIVO® 2heal® Embolisation Device for Intracranial Aneurysms
Lead sponsor
Acandis GmbH
Phase
Observational
Overall status
Recruiting
Start date
December 15, 2022
Completion date
December 31, 2026
Enrollment
158 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

flow diverter, intracranial aneurysm